Search Results 21-30 of 14673 for remdesivir
The FDA-approved remdesivir is an antiviral drug to treat COVID-19 in the hospital or similar care settings, with continuation of IV therapy in the outpatient ...
As for antiviral therapies, such as remdesivir, that work against the virus through a mechanism that does not involve the spike protein, Dr. Badley says it ...
We have a number of drugs: monoclonal antibodies, remdesivir, steroids and some immune-modifying drugs that we can use in the hospitalized setting. We are ...
Medicines for severe COVID-19 may be remdesivir, baricitinib (Olumiant) and tocilizumab (Actemra), or a corticosteroid such as dexamethasone. Baricitinib is a ...
The primary objective of this study is to evaluate whether remdesivir (RDV, GS-5734™) reduces the composite risk of death or invasive mechanical ventilation ( ...
Remdesivir needs to be administered intravenously daily for five days. Previously, patients who were otherwise ready for discharge might have remained in ...
The purpose of this study is to evaluate the effietiveness of remdesivir (RDV) in reducing the rate of of all-cause medically attended visits (MAVs; medical ...
Two antiviral drugs, called remdesivir and Paxlovid, are currently approved to treat COVID-19 . Researchers are evaluating many drugs and treatments for ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.